Moving beyond the breast cancer screening debate

Journal of Women's Health

Volumn 23, Issue 8, 2014, Pages 629-630

  Esserman, Laura ^a   O'Kane, Margaret E ^b  

^a NATIONAL COMMITTEE FOR QUALITY ASSURANCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

ADJUVANT THERAPY; BREAST CANCER; CANCER SCREENING; EDITORIAL; FEMALE; FOLLOW UP; HUMAN; MAMMOGRAPHY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; ADULT; BREAST NEOPLASMS; EARLY DIAGNOSIS; LABORATORY DIAGNOSIS; MIDDLE AGED; UNNECESSARY PROCEDURE;

ADULT; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; UNNECESSARY PROCEDURES;

EID: 84905964383     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2014.4860     Document Type: Editorial

References (19)

1. National Committee for Quality Assurance (NCQA). Proposed changes to existing measure for HEDIS 2014: Breast Cancer Screening (BCS). https://www.ncqa.org/Portals/0/PublicComment/HEDIS2014/2.%20BCS%20Materials.pdf
2. American Cancer Society Guidelines for the Early Detection of Cancer. Available at www.cancer.org/healthy/findcancerearly/cancerscreeningguidelines/ american-cancer-society-guidelines-for-the-early-detection-of-cancer Accessed June 5, 2014.
3. Miller AB, Wall C, Baines CJ, et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: Randomized screening trial. BMJ 2014;348:g366.
4. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605-613.
5. Esserman LJ, Shieh Y, Rutgers EJ, et al. Impact of mammo-graphic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat 2011;130:725-734.
6. Esserman LJ, Thompson IM, Jr., Reid B. Overdiagnosis and overtreatment in cancer: An opportunity for improvement. JAMA 2013;310:797-798.
7. Esserman LJ, Thompson IM, Reid B, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol 2014;15:e234-242.
8. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 2014;311:1327-1335.
9. Biller-Andorno N, Jüni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med 2014;370:1965-1967.
10. Committee on a Framework for Development a New Taxonomy of Disease; National Research Council. Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. Washington, DC: National Academies Press, 2011.
11. Esserman LJ, Thompson IM, Reid B, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol 2014;15:e234-242.
12. Flowers CI, O'Donoghue C, Moore D, et al. Reducing false-positive biopsies: A pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat 2013;139:769-777.
13. O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ. Aggregate cost of mammography screening in the United States: Comparison of current practice and advocated guidelines. Ann Intern Med 2014;160:145.
14. Elmore JG, Gross CP. The cost of breast cancer screening in the United States: A picture is worth.a billion dollars? Ann Intern Med 2014;160:203.
15. Webb ML, Cady B, Michaelson JS, et al. A failure analysis of invasive breast cancer: Most deaths from disease occur in women not regularly screened. Cancer 2013 [Epub ahead of print]; DOI: 10.1002/cncr.28199
16. Berry, Donald A. Breast cancer screening: Controversy of impact. Breast 2013;22:S73-S76.
17. Berry DA. Failure of researchers, reviewers, editors, and the media to understand flaws in cancer screening studies. Cancer 2014. doi: 10.1002/cncr.28795. [Epub ahead of print]
18. Kopans, Daniel B. Mammograms save lives: Criticism of breast-cancer screenings is more about rationing than rationality. Wall Street Journal, May 22, 2014. Available at http://online.wsj.com/news/article-email/ SB1000142405270230 4547704579564440536353948-lMyQjAxMTA0MDIwMjEy NDIyWj Accessed June, 4, 2014.
19. Eklund M, Esserman LJ. Screening: Biology dictates the fate of young women with breast cancer. Nat Rev Clin Oncol 2013;10:673-675.